These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8208425)

  • 1. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin.
    Counsell CE; McLeod M; Grant R
    Neurology; 1994 Jun; 44(6):1184-5. PubMed ID: 8208425
    [No Abstract]   [Full Text] [Related]  

  • 2. [The association of the Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of nonparaneoplastic origin].
    García Castañón I; Corral I; de Blas G; Fernández Ruiz LC
    Med Clin (Barc); 1995 Mar; 104(8):303-5. PubMed ID: 7700091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic multiple paraneoplastic syndromes.
    Kleopa KA; Teener JW; Scherer SS; Galetta SL; Bird SJ
    Muscle Nerve; 2000 Nov; 23(11):1767-72. PubMed ID: 11054759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the paraneoplastic Lambert-Eaton syndrome].
    Courau E; Westeel V; Jacoulet P; Depierre A
    Rev Pneumol Clin; 1998 May; 54(2):65-70. PubMed ID: 9769989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration.
    Recht L
    J Neurol Neurosurg Psychiatry; 1993 Dec; 56(12):1338. PubMed ID: 8270943
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic syndromes: a challenge for neuroscience nursing.
    Alexander J; Foltz A; Parylovich K
    J Neurosci Nurs; 1993 Aug; 25(4):228-32. PubMed ID: 8228394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
    Goldstein JM; Waxman SG; Vollmer TL; Lang B; Johnston I; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1138-9. PubMed ID: 8089692
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.
    Bird SJ
    Neurology; 1992 Jul; 42(7):1422-3. PubMed ID: 1620360
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumour therapy in paraneoplastic neurological disease.
    Grisold W; Drlicek M; Liszka-Setinek U; Wondrusch E
    Clin Neurol Neurosurg; 1995 Feb; 97(1):106-11. PubMed ID: 7788965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Eaton-Lambert myasthenic syndrome and subacute cerebellar degeneration of a nonparaneoplastic origin: a review of a case 4 years later].
    Graus F; Basart E; Fernández Ruiz LC
    Med Clin (Barc); 1999 Jan; 112(2):79. PubMed ID: 10065441
    [No Abstract]   [Full Text] [Related]  

  • 13. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic syndromes affecting the central nervous system.
    Posner JB; Dalmau JO
    Annu Rev Med; 1997; 48():157-66. PubMed ID: 9046952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
    Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
    J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic syndromes in neuro-ophthalmology.
    Alabduljalil T; Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):463-9. PubMed ID: 18162997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic syndromes: a review].
    Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
    Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-Eaton (myasthenic) syndrome: pre-anaesthetic treatment with intravenous immunoglobulins.
    Biarnés A; Rochera MI
    Anaesthesia; 1996 Aug; 51(8):797. PubMed ID: 8795338
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune modulation of paraneoplastic neurologic disorders.
    Graus F; Delattre JY
    Clin Neurol Neurosurg; 1995 Feb; 97(1):112-6. PubMed ID: 7788966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.